NARA Discovery
Article Details
← Back to Search Results
Journal Article

Supercritical fluid (SCF)-assisted preparation of cyclodextrin-based poly(pseudo)rotaxanes for transdermal purposes

Gleidson Cardoso; Carlos A. García Gonzalez; Víctor Santos-Rosales; Stephania Fleury Taveira; Marcilio Cunha-Filho; Angel Concheiro; Carmen Alvarez-Lorenzo; Ricardo Neves Marreto
Drug Delivery and Translational Research · Vol. 14, Issue 1 · pp. 103-115 · 2024

Abstract

This study aims to investigate the effect of the preparation of solid dispersions using supercritical CO 2 (scCO 2 ) on the physicochemical properties and the performance of supramolecular gels based on polymer-cyclodextrin (CD) interactions (named poly(pseudo)rotaxanes, PPR) envisaging a transdermal administration. Solid dispersions containing Soluplus ® , the antihypertensive drug carvedilol (CAR), and CD (αCD or HPβCD) were prepared and characterized by HPLC, XRPD, FTIR, and DSC. PPRs prepared from solid dispersions (SCF gels) and the corresponding physical mixtures (PM gels) were analyzed regarding rheology, morphology, in vitro drug diffusion, and ex vivo drug skin permeation. The application of scCO 2 led to the loss of the crystalline lattice of CAR while preserving its chemical identity. On the contrary, αCD crystals were still present in the SCF solid dispersions. SCF gels were more uniform than their corresponding PM, and the supercritical treatment resulted in changes in the rheological behavior, reducing the viscosity. CAR in vitro diffusion was significantly higher ( p < 0.05) for the αCD-based SCF gel than its corresponding PM gel. Drug skin permeation showed a significant increase in drug flux from CD-based SCF gels (containing αCD or HPβCD) compared to corresponding PM gels. Additionally, the pretreatment of the skin with αCD exhibited increased CAR permeation, suggesting an interaction between αCD and the skin membrane. Results evidenced that SCF processing decisively modified the properties of the supramolecular gels, particularly those prepared with αCD. Graphical Abstract

Bibliographic Information

JournalDrug Delivery and Translational Research
PublisherSpringer
Publication Date2024-01-01
Publication Year2024
Volume14
Issue1
Pages103-115
Document TypeJournal Article
Print ISSN2190-393X
eISSN2190-3948
DOI10.1007/s13346-023-01385-w

Access Information

NARA Access Coverage2011-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13346
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.